NSESpurt in Volume1 Jul 2026 · 1 Jul 2026, 02:50 pm

Spurt in Volume

SMS Pharmaceuticals Limited · SMSPHARMA

✦ AI SummaryRegulatory

SMS Pharmaceuticals Limited has responded to the National Stock Exchange's (NSE) query regarding a spurt in volume of its equity shares, stating that the company has been complying with all material event disclosures and has not withheld any price-sensitive information.

Analysis Scores

Earnings Impact5/10

Growth Catalyst3/10

Governance Concern2/10

Regulatory Risk8/10

Balance Sheet Risk2/10

Liquidity Impact6/10

Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

Full Announcement

Significant increase in volume has been observed in SMS Pharmaceuticals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. SMS Pharmaceuticals Limited has submitted their response.

Attachments (1)

📄

SMSPHARMA_01072026145019_Clarification_to_NSE_01072026.pdf

pdf

Download →

View document text

Date: 01st July, 2026 The Manager, Surveillance Department, National Stock Exchange of India Ltd. Exchange Plaza, Plot no. C/1, G Block, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 051. Symbol: SMSPHARMA Dear Sir/Madam, Sub: Clarification with respect to spurt in volume Ref.: NEAPS Clarification on spurt in volume, news sequence no. 17190 dated 30th June, 2026 This has reference to the clarification sought from the Company on 30th June, 2026 regarding the spurt in volume of equity shares of SMS Pharmaceuticals Limited. In this regards we would like to inform you that, the company has been duly complying and diligently disclosing all the material events, information, that have a bearing on the operations/performance of the Company which include all price sensitive information in accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 from time to time. The Company has not withheld any material information /announcement/ event that in our opinion would have a bearing on the price/volume behavior in our shares. We hereby submit that, in relation to the spurt in volume of shares of the company which is purely due to market conditions and absolutely market driven. Please take the same on your records. Thanking you Yours Faithfully For SMS Pharmaceuticals Limited Thirumalesh Tumma Company Secretary